- Home
- OCC vs RNXT Comparison
OCC vs RNXT Comparison
Compare OCC & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCC
- RNXT
- Stock Information
- Founded
- OCC 1983
- RNXT 2012
- Country
- OCC United States
- RNXT United States
- Employees
- OCC N/A
- RNXT N/A
- Industry
- OCC Telecommunications Equipment
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- OCC Industrials
- RNXT Health Care
- Exchange
- OCC Nasdaq
- RNXT Nasdaq
- Market Cap
- OCC 40.9M
- RNXT 44.6M
- IPO Year
- OCC 1996
- RNXT 2021
- Fundamental
- Price
- OCC $5.32
- RNXT $0.94
- Analyst Decision
- OCC
- RNXT Strong Buy
- Analyst Count
- OCC 0
- RNXT 2
- Target Price
- OCC N/A
- RNXT $7.25
- AVG Volume (30 Days)
- OCC 74.1K
- RNXT 194.0K
- Earning Date
- OCC 09-10-2025
- RNXT 08-14-2025
- Dividend Yield
- OCC N/A
- RNXT N/A
- EPS Growth
- OCC N/A
- RNXT N/A
- EPS
- OCC N/A
- RNXT N/A
- Revenue
- OCC $68,999,601.00
- RNXT $662,000.00
- Revenue This Year
- OCC N/A
- RNXT $3,104.65
- Revenue Next Year
- OCC N/A
- RNXT $301.89
- P/E Ratio
- OCC N/A
- RNXT N/A
- Revenue Growth
- OCC 5.77
- RNXT N/A
- 52 Week Low
- OCC $2.02
- RNXT $0.75
- 52 Week High
- OCC $7.00
- RNXT $1.69
- Technical
- Relative Strength Index (RSI)
- OCC 53.31
- RNXT 29.33
- Support Level
- OCC $5.01
- RNXT $1.23
- Resistance Level
- OCC $6.06
- RNXT $1.37
- Average True Range (ATR)
- OCC 0.54
- RNXT 0.09
- MACD
- OCC -0.09
- RNXT -0.02
- Stochastic Oscillator
- OCC 57.34
- RNXT 8.51
About OCC Optical Cable Corporation
Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, renewable energy and broadcast applications, and for the wireless carrier market.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.